Actinium Pharmaceuticals, Inc. (ATNM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated November 26, 2025, reports on the results of Actinium Pharmaceuticals, Inc.'s 2025 Annual Meeting of Stockholders. The meeting was held to elect directors, ratify the independent auditor, and vote on executive compensation matters.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes.
Material Changes and Voting Results
At the Annual Meeting, 15,494,573 shares were present in person or by proxy out of 31,195,891 shares outstanding as of the October 15, 2025 record date. All proposals were approved by stockholders:
- Election of Directors: Ajit S. Shetty and June S. Almenoff were elected as Class III directors for a three-year term expiring in 2028.
- Auditor Ratification: Stockholders ratified the appointment of CBIZ as the independent registered public accounting firm for the fiscal year ending December 31, 2025.
- Executive Compensation: Stockholders approved the compensation of named executive officers on a non-binding advisory basis.
- Compensation Vote Frequency: Stockholders approved a three-year frequency for future advisory votes on executive compensation.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the final voting results of the Annual Meeting.
Key Facts for Investor Verification
- Verify the re-election of Ajit S. Shetty and June S. Almenoff to the Board of Directors.
- Confirm the ratification of CBIZ as the independent auditor for the 2025 fiscal year.
- Note the significant number of broker non-votes (9,354,877) on director elections and executive compensation proposals.
- Review the definitive Proxy Statement filed on November 5, 2025, for detailed background on the proposals.